Notice ID: 8b2e55002f7844d5b6b3d7cda4a32dedAward NoticeAwarded
AN13--Accelerating VA Innovation and Learning (AVAIL) DHL
Awarded on September 27, 2022. Full description on SAM.gov.
Awarded tounder 36C10X22D0028 (source: SAM.gov award notice)• $0
Overview
- Posted
- September 27, 2022
- Notice type
- Award Notice
- NAICS
- 541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Agency
- Department of Veterans Affairs
Notice details
- Last updated
- Sep 9, 2025
- Award date
- Sep 27, 2022
- Award amount (SAM.gov award notice)
- $0
Identifiers
- Solicitation number
- 36C10X22R0027
- Notice ID
- 8b2e55002f7844d5b6b3d7cda4a32ded
- Award number (PIID)
- 36C10X22D0028
Description
The Department of Veterans Affairs (VA), Veterans Health Administration (VHA) is Americas largest integrated health care system with over 1,700 sites of care, serving 8.76 million Veterans each year. For decades, the Veterans Health Administration has been a pioneer and leader in healthcare innovation. Today, wearable technologies, big data, machine learning and artificial intelligence, 3-D printing, and telehealth capabilities are driving significant and growing segments within the healthcare market. These emerging technologies, which are poised to transform care experience and service, can require enormous up-front investments and if not carefully designed, developed, and validated and/or tested in real-world settings, can yield little value to healthcare system or the patients it serves. The Office of Healthcare Innovation and Learning (OHIL) leads VHA efforts to design, develop, and test new healthcare solutions, services (including funding models) and care models of care that can advance VHAs mission to provide world class care and experience to Veterans. The office consists of three core programs: SimLEARN, including the National Simulation Center; The VHA Innovation Ecosystem; and The Center for Care and Payment Innovation. Collectively, these offices create a synergistic and advanced collaborative team which has successfully designed, developed, tested, and scaled multiple healthcare innovations used throughout the American healthcare system. The Office of Healthcare Innovation and Learning is also part of VHA DEAN Discovery, Education and Affiliate Networks in which it shares a common mission with its sister offices, Office of Academic Affiliate and Office of Research and Development, to advance VHAs urney to excel as a learning organization that amplifies innovation. The AVAIL Accelerating VA Innovation and Learning contract serves as an opportunity to further VAs long-standing tradition as a pioneer in medical innovation and VHAs journey towards excelling as a learning organization by offering VHA, and the Office of Healthcare Innovation and Learning, the availability to augment its ongoing design, development and testing efforts around healthcare innovation. The Office of Healthcare Innovation has identified 5 major innovation task categories or growth areas in which ongoing efforts are focused on: (1) Personalized Care; (2) Data Transformation; (3) Digital Care; (4) Immersive Technology; and (5) Care and Service Delivery Models. AVAIL will augment VHA and OHILs capacity, through subject matter expertise, to design, develop and test novel solutions and accompanying care and service models in a real-world setting (in this case, the Veterans Health Administration), ensuring that solutions create meaningful value for VHA clinicians, administrators, caregivers, and most importantly, Veterans, before being scaled into clinical production.
Award Overview
Award Number
36C10X22D0028
Award Amount (SAM.gov award notice)
$0
Award Date
Sep 27, 2022
Awardee
Awardee UEI
HJF7VK5P3DL4
Original Solicitation
Notice ID: 8b2e55002f7844d5b6b3d7cda4a32ded
Posted Date: Sep 27, 2022
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Jul 9, 2025
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C10X22R0027- Combined Synopsis
- Awarded
This opportunity has been awarded.
- 6×Combined SynopsisMay 16, 2022
AN13 - Accelerating VA Innovation and Learning (AVAIL)
- 17×AwardedCurrentSep 27, 2022
AN13--Accelerating VA Innovation and Learning (AVAIL) DHL
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product. The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022. NOTE: Another amendment will be posted which will include Offeror questions and Government responses. (Amendment 0003 only extends the proposal due date). | - | Solicitation | 11/20/2026 |
The Defense Health Agency Contracting Activity (DHACA) intends to issue a sole source award. The Defense Health Agency, Science and Technology Portfolio Management Division (STPMD) will co-sponsor a Forum on Traumatic Brain Injury (TBI) hosted by the National Academy of Science, Engineering, and Medicine (NASEM). The forum will provide STPMD on ongoing mechanism and neutral setting in which the full spectrum of Government stakeholders and public and private sector Subject Matter Experts (SMEs) to explore opportunities for collective action directed towards advancement in TBI care and research. The requirement contains a base year plus 4 option years. The NASEM will convene the Forum on TBI two (2) to three (3) times per year to provide and ongoing mechanism and neutral setting in which the full spectrum of Government stakeholders and public and private sector SMEs will share information and explore opportunities for collective action addressing contemporary topics in TBI and research. Forum members will address short- and long-term strategic planning for advancing TBI care and research spanning the full TBI continuum from prevention through acute care and rehabilitation. NASEM has established these forums as part of contract W81XWH22C0033. DHA is planning to participate as a key stakeholder. STPMD requires access to these Forums along with other military services and federal agencies. Any firm that believes it can provide the stated capability as outlined above are invited to submit a written notification to the Contracting Office NLT 2PM ET on 18 November 2026. Supporting evidence must be furnished in sufficient detail to demonstrate the firm’s ability to provide the stated capability. Information shall be sent electronically (via e-mail only) to Rich Trunnell, Contract Specialist, at richard.k.trunnell.civ@health.mil. No telephone requests will be accepted. Responses received will be evaluated; however; a determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, DHACA will proceed with the sole sources contract. | - | Special Notice | 11/18/2026 |
Redacted Justification and Approval (J&A) for Other than Full and Open Competition to award a new firm fixed price Research and Development contract to obtain the Product Lifecycle Management (PLM) activities necessary to sustain the commercial viability of a Single Donor, Type Specific, universal Freeze-Dried Plasma (FDP) product made by Vascular Solutions LLC (a subsidiary of Teleflex Incorporated). | - | Awarded | Open |
The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration’s requirements for EZPLAZ™ approval. | - | Market Research | 11/16/2026 |
This is a Small Business Sources Sought (SBSS) Notice for Research and Development (R&D). This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of qualified small businesses under the size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. The anticipated North American Industry Classification System (NAICS) code is 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and the small business size standard for such requirements is 1,000 employees or less, including applicable affiliates. This SBSS notice is for market research and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the Government. The purpose of this synopsis is to identify small business organizations with requisite qualifications to provide the services stated herein. Based on capability statements received in response to this Sources Sought Announcement, this acquisition may be solicited as a small business set-aside. All small business organizations (SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB) are encouraged to respond to this notice. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. | - | Market Research | 11/23/2026 |
Additional Details
Solicitation Number
36C10X22R0027
Archive Date
Nov 26, 2022
Office Address
FREDERICK, MD, 21703